HDL metabolism and activity in chronic kidney disease.
Vaziri
Nosratola D
ND
Division of Nephrology and Hypertension, School of Medicine, The City Drive, City Tower, Suite 400, Orange, CA 92868-3217, USA. ndvaziri@uci.edu
Navab
Mohamad
M
Fogelman
Alan M
AM
D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D050197:Atherosclerosis / Q000209:etiology* / Q000378:metabolism* / Q000503:physiopathology; D018450:Disease Progression; D004198:Disease Susceptibility; D015536:Down-Regulation; D050171:Dyslipidemias / Q000209:etiology* / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000378:metabolism* / Q000503:physiopathology; D008075:Lipoproteins, HDL / Q000378:metabolism*; D018384:Oxidative Stress
D000975:Antioxidants; D008075:Lipoproteins, HDL